Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6‐month trimethoprim‐sulfamethoxazole prophylaxis: A case‐control study-Reference-Cited by-同舟云学术

Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6‐month trimethoprim‐sulfamethoxazole prophylaxis: A case‐control study

Published:2020-01-24 Issue:2 Volume:22 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Park Se Yoon¹²^ORCID,Jung Joo Hee³,Kwon Hyunwook³,Shin Sung³,Kim Young Hoon³,Chong Yong‐Phil¹,Lee Sang‐Oh¹,Choi Sang‐Ho¹,Kim Yang Soo¹,Woo Jun Hee¹,Kim Sung‐Han¹^ORCID,Han Duck Jong³

Affiliation:

1. Department of Infectious Diseases Asan Medical Center University of Ulsan College of Medicine Seoul Korea

2. Division of Infectious Diseases Department of Internal Medicine Soonchunhyang University Seoul Hospital Soonchunhyang University College of Medicine Seoul Korea

3. Department of Surgery Asan Medical Center University of Ulsan College of Medicine Seoul Korea

Funder

Korea Health Industry Development Institute

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13245

Reference20 articles.

1. Pneumocystis jirovecii pneumonia in kidney transplantation

2. Pneumocystispneumonia in solid organ transplant recipients: not yet an infection of the past